Literature DB >> 15504056

Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.

Diane D Davey1, Margaret H Neal, David C Wilbur, Terence J Colgan, Patricia E Styer, Dina R Mody.   

Abstract

CONTEXT: The 2001 Bethesda System for the reporting of cervical cytology specimens and the use of new liquid-based and human papillomavirus testing technologies have led to changes in cervical cytology reporting practices.
OBJECTIVES: To analyze current laboratory reporting practices using Bethesda 2001 terminology and to compare results with previous survey data from 1996.
DESIGN: Questionnaire survey mailed to 1751 laboratories in mid-2003. PARTICIPANTS: Laboratories enrolled in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
RESULTS: Of the 759 responding laboratories, most (85.5%) had implemented Bethesda 2001 terminology, and the majority had adopted major changes, such as elimination of the benign cellular changes category and the satisfactory but limited category. The median reporting rate for low-grade squamous intraepithelial lesion was 2.1%, compared to a 1996 median rate of 1.6%, but the increase was confined to liquid-based preparations. Reporting rates for high-grade squamous intraepithelial lesion (median, 0.5%) and atypical squamous cells (ASC) had changed little. Most ASC cases were subclassified as "undetermined significance" (median, 3.9%) with ASC, cannot exclude high-grade SIL accounting for a minority (median, 0.2%). The median ratio of ASC to squamous intraepithelial lesions and carcinomas (SIL+) was 1.4 and was lower than the 1996 median ratio of 2.0. Median reporting rates for squamous abnormalities for 2002 were noted to be significantly higher for liquid-based preparations than for conventional smears, while median ASC/SIL+ ratios were lower. Most laboratories offer human papillomavirus testing, but almost half (47%) of laboratories do not know the percentage of positive testing results in patients with ASC.
CONCLUSIONS: Most laboratories have implemented Bethesda 2001 terminology. New criteria and liquid-based methods have led to an increase in low-grade squamous intraepithelial lesion reporting rates and a decrease in ASC/ SIL+ ratios when compared with 1996 data. Liquid-based preparations have higher median squamous intraepithelial lesion rates and lower ASC/SIL+ ratios than conventional smears.

Entities:  

Mesh:

Year:  2004        PMID: 15504056     DOI: 10.5858/2004-128-1224-BIARRP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  21 in total

1.  Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.

Authors:  Linda M Niccolai; Pamela J Julian; Alyssa Bilinski; Niti R Mehta; James I Meek; Daniel Zelterman; James L Hadler; Lynn Sosa
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.

Authors:  Seoyoung C Kim; Victoria G Gillet; Sarah Feldman; Huichuan Lii; Sengwee Toh; Jeffrey S Brown; Jeffrey N Katz; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-09-12       Impact factor: 2.890

3.  Rapid Antimicrobial Susceptibility Testing Using Forward Laser Light Scatter Technology.

Authors:  Randall T Hayden; Lani K Clinton; Carolyn Hewitt; Terri Koyamatsu; Yilun Sun; Ginger Jamison; Rosalie Perkins; Li Tang; Stanley Pounds; Matthew J Bankowski
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

4.  Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images.

Authors:  Angela H Liu; Michael A Gold; Mark Schiffman; Katie M Smith; Rosemary E Zuna; S Terence Dunn; Julia C Gage; Joan L Walker; Nicolas Wentzensen
Journal:  J Low Genit Tract Dis       Date:  2016-04       Impact factor: 1.925

Review 5.  Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

6.  Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.

Authors:  Philip E Castle; Vânia R S Silva; Marcia E L Consolaro; Nádia Kienen; Lorna Bittencourt; Sandra M Pelloso; Edward E Partridge; Amanda Pierz; Camila B Dartibale; Nelson S Uchimura; Isabel C Scarinci
Journal:  Cancer Prev Res (Phila)       Date:  2019-01-16

7.  Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.

Authors:  Qin-Jing Pan; Shang-ying Hu; Xun Zhang; Pu-wa Ci; Wen-hua Zhang; Hui-qin Guo; Jian Cao; Fang-hui Zhao; Alice Lytwyn; You-lin Qiao
Journal:  Cancer Cytopathol       Date:  2013-04-23       Impact factor: 5.284

8.  Multiple biopsies and detection of cervical cancer precursors at colposcopy.

Authors:  Nicolas Wentzensen; Joan L Walker; Michael A Gold; Katie M Smith; Rosemary E Zuna; Cara Mathews; S Terence Dunn; Roy Zhang; Katherine Moxley; Erin Bishop; Meaghan Tenney; Elizabeth Nugent; Barry I Graubard; Sholom Wacholder; Mark Schiffman
Journal:  J Clin Oncol       Date:  2014-11-24       Impact factor: 44.544

9.  A Shandon PapSpin liquid-based gynecological test: A split-sample and direct-to-vial test with histology follow-up study.

Authors:  J Rimiene; J Petronyte; Z Gudleviciene; Giedre Smailyte; Ingrida Krasauskaite; A Laurinavicius
Journal:  Cytojournal       Date:  2010-03-20       Impact factor: 2.091

10.  Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.

Authors:  Anna K Wong; Raymond C-K Chan; W Stephen Nichols; Shikha Bose
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.